Fig. 5From: Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm studyOverall survival (OS)Â A Kaplan-Meier curve of OS in the modified intent-to-treat population. B Kaplan-Meier curve of OS in the triple-class refractory population. C Kaplan-Meier curve of OS by best response.Back to article page